Mr. Koenig

Sheldon L. Koenig has served as Esperion Therapeutics’ Chief Executive Officer and a member of its Board since May 2021.

4 documented relationships

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Mr. KoenigEmploymentMerck
Reported^{1Leadership Team | Esperion Therapeutics, Inc.esperion.com}
Position or object indicated by the source: “Vice President and Global Brand Leader for the cardiovascular division”.
Mr. KoenigEmploymentSanofi S.A.
2016 · 2018Reported^{1Leadership Team | Esperion Therapeutics, Inc.esperion.com}
Role or object indicated by the source: “Senior Vice President and Head of the cardiovascular franchise”.
Mr. KoenigEmploymentPortola Pharmaceuticals, Inc.
2019 · 2020Reported^{1Leadership Team | Esperion Therapeutics, Inc.esperion.com}
Role or object indicated by the source: “Executive Vice President and Chief Commercial Officer”.
Mr. KoenigEmploymentEsperion Therapeutics, Inc.
December 2020Reported^{1Leadership Team | Esperion Therapeutics, Inc.esperion.com}
Position or object indicated by the source: “Chief Operating Officer”.

Sources

1.
Leadership Team | Esperion Therapeutics, Inc.
Web pageesperion.com
View original ↑ Back to text